Lowest-Rated StocksLowest-RatedNYSE:PATH UiPath (PATH) Stock Price, News & Analysis $11.56 -0.04 (-0.30%) As of 02:36 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About UiPath Stock (NYSE:PATH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get UiPath alerts:Sign Up Key Stats Today's Range$11.42▼$11.6350-Day Range$10.43▼$13.3452-Week Range$9.38▼$15.93Volume3.72 million shsAverage Volume11.80 million shsMarket Capitalization$6.14 billionP/E Ratio385.50Dividend YieldN/APrice Target$13.18Consensus RatingHold Company Overview UiPath Inc. provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization. Its platform's embedded AI, ML, and NLP capabilities improve decisioning and information processing; emulate human behavior allows organizations to address a myriad of use cases; emulate human behavior allows organizations to address a myriad of use cases; multi-tenant platform enterprise deployment with security and governance and Automation Cloud, which enables customers to begin automating without the need to provision infrastructure, install applications, or perform additional configurations; intuitive interface and low-code, drag-and-drop functionality; signed to enable people and automations to work together; and tracks, measures, and forecasts the performance of automations, enables customers to gain powerful insights and generate key performance indicators with actionable metric. It serves banking and financial services, healthcare, insurance, public sectors, manufacturing, retail, and telecom industries. The company was founded in 2005 and is headquartered in New York, New York. Read More UiPath Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks58th Percentile Overall ScorePATH MarketRank™: UiPath scored higher than 58% of companies evaluated by MarketBeat, and ranked 371st out of 666 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.2 / 5Analyst RatingHold Consensus RatingUiPath has received a consensus rating of Hold. The company's average rating score is 2.12, and is based on 2 buy ratings, 12 hold ratings, and 2 sell ratings.Upside PotentialUiPath has a consensus price target of $13.18, representing about 13.9% upside from its current price of $11.58.Amount of Analyst CoverageUiPath has been the subject of 7 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about UiPath's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for UiPath are expected to grow in the coming year, from ($0.17) to ($0.16) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of UiPath is 385.93, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 280.80.Price to Earnings Ratio vs. SectorThe P/E ratio of UiPath is 385.93, which means that it is trading at a less expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 448.86.Price to Earnings Growth RatioUiPath has a PEG Ratio of 4.36. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioUiPath has a P/B Ratio of 3.48. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about UiPath's valuation and earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted13.79% of the float of UiPath has been sold short.Short Interest Ratio / Days to CoverUiPath has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in UiPath has recently increased by 1.61%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldUiPath does not currently pay a dividend.Dividend GrowthUiPath does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted13.79% of the float of UiPath has been sold short.Short Interest Ratio / Days to CoverUiPath has a short interest ratio ("days to cover") of 4.8.Change versus previous monthShort interest in UiPath has recently increased by 1.61%, indicating that investor sentiment is decreasing. News and Social Media3.2 / 5News Sentiment0.80 News SentimentUiPath has a news sentiment score of 0.80. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 17 news articles for UiPath this week, compared to 14 articles on an average week.Search Interest95 people have searched for PATH on MarketBeat in the last 30 days. This is an increase of 56% compared to the previous 30 days.MarketBeat Follows51 people have added UiPath to their MarketBeat watchlist in the last 30 days. This is an increase of 219% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, UiPath insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $10,969,372.00 in company stock.Percentage Held by Insiders23.19% of the stock of UiPath is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions62.50% of the stock of UiPath is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about UiPath's insider trading history. Receive PATH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for UiPath and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PATH Stock News HeadlinesUiPath (NYSE:PATH) CEO Daniel Dines Sells 45,000 SharesSeptember 11, 2025 | insidertrades.com3 Robotics Stocks at the Heart of the Robotics RevolutionRobotics is a logical extension of the AI revolution, these three robotics stocks bring AI-driven growth to healthcare, logistics, and enterprise software...August 21, 2025 | marketbeat.comNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal comes from the same team that helped guide ANOTHER rare disease biotech to a $680M acquisition. Now, they've lined up a new candidate: a drug with orphan status and fast-track designation, entering Phase 2 trials.September 16 at 2:00 AM | i2i Marketing Group, LLC (Ad)UiPath's Leadership in Intelligent Document Processing Might Change The Case For Investing In PATH4 hours ago | finance.yahoo.comUiPath Inc. Appoints Michael Atalla as Chief Marketing Officer to Lead Agentic AI StrategySeptember 11, 2025 | insidermonkey.comUiPath Inc. Appoints Michael Atalla as Chief Marketing Officer to Lead Agentic AI StrategySeptember 11, 2025 | msn.comShould You Buy, Sell, or Hold UiPath Stock After Q2 Earnings?September 11, 2025 | msn.comThe 5 Most Interesting Analyst Questions From UiPath’s Q2 Earnings CallSeptember 11, 2025 | finance.yahoo.comSee More Headlines PATH Stock Analysis - Frequently Asked Questions How have PATH shares performed this year? UiPath's stock was trading at $12.71 at the start of the year. Since then, PATH stock has decreased by 8.9% and is now trading at $11.5750. How were UiPath's earnings last quarter? UiPath, Inc. (NYSE:PATH) released its earnings results on Thursday, September, 4th. The company reported $0.15 EPS for the quarter, topping analysts' consensus estimates of $0.08 by $0.07. The business's revenue for the quarter was up 14.6% compared to the same quarter last year. Read the conference call transcript. Does UiPath have any subsidiaries? UiPath subsidiaries include Re:infer, Cloud Elements, UiPath Process Mining, StepShot, Cloud Elements Inc., CloudElements Technologies India Private Limited, MagnaView BV, and more. When did UiPath IPO? UiPath (PATH) raised $990 million in an IPO on Wednesday, April 21st 2021. The company issued 21,300,000 shares at a price of $43.00-$50.00 per share. Morgan Stanley, JPMorgan, BofA Securities, Credit Suisse, Barclays and Wells Fargo Securities served as the underwriters for the IPO and SMBC Nikko, BMO Capital Markets, Mizuho Securities USA, KeyBanc Capital Markets, TD Securities (USA), Truist SecuritiesCowen, Evercore Group, Macquarie Capital (USA), Nomura, RBC Capital Markets, Canaccord Genuity, D. A. Davidson & Co., Oppenheimer & Co. and Needham & Co. were co-managers. Who are UiPath's major shareholders? UiPath's top institutional investors include TFG Asset Management GP Ltd (2.56%), AQR Capital Management LLC (2.13%), Bank of America Corp DE (1.94%) and Senvest Management LLC (1.85%). Insiders that own company stock include Daniel Dines, Ashim Gupta, Brad Brubaker, Rich Wong and Hitesh Ramani. View institutional ownership trends. How do I buy shares of UiPath? Shares of PATH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of UiPath own? Based on aggregate information from My MarketBeat watchlists, some other companies that UiPath investors own include NVIDIA (NVDA), Enovix (ENVX), Rambus (RMBS), Saia (SAIA), Meta Platforms (META), COMPASS Pathways (CMPS) and Company Calendar Last Earnings9/04/2025Today9/16/2025Next Earnings (Estimated)12/04/2025Fiscal Year End1/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry INTERNET SOFTWARE Sub-IndustryComputer Software Current SymbolNYSE:PATH Previous SymbolNYSE:PATH CIK1734722 Webwww.uipath.com Phone844-432-0455FaxN/AEmployees3,868Year Founded2005Price Target and Rating Average Price Target for UiPath$13.18 High Price Target$18.00 Low Price Target$10.00 Potential Upside/Downside+13.6%Consensus RatingHold Rating Score (0-4)2.12 Research Coverage17 Analysts Profitability EPS (Trailing Twelve Months)$0.03 Trailing P/E Ratio386.67 Forward P/E RatioN/A P/E Growth4.36Net Income-$73.69 million Net Margins1.35% Pretax Margin0.85% Return on Equity1.28% Return on Assets0.83% Debt Debt-to-Equity RatioN/A Current Ratio2.75 Quick Ratio2.75 Sales & Book Value Annual Sales$1.43 billion Price / Sales4.31 Cash Flow$0.03 per share Price / Cash Flow375.82 Book Value$3.33 per share Price / Book3.48Miscellaneous Outstanding Shares531,020,000Free Float407,878,000Market Cap$6.16 billion OptionableOptionable Beta1.02 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:PATH) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | SponsoredSean Hannity: Help Protect Your RetirementThis Guide to retirement protection has helped thousands protect over $3 billion dollars in retirement savings...Goldco Precious Metals | SponsoredWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredREVEALED: Something Big Happening Behind White House Doorswhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding UiPath, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share UiPath With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
